» Authors » Raymond L Stallings

Raymond L Stallings

Explore the profile of Raymond L Stallings including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 2867
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Creevey L, Ryan J, Harvey H, Bray I, Meehan M, Khan A, et al.
Mol Cancer . 2013 Mar; 12:23. PMID: 23531080
Background: Neuroblastoma is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25-40%). MiR-497...
22.
Althoff K, Beckers A, Odersky A, Mestdagh P, Koster J, Bray I, et al.
Int J Cancer . 2013 Feb; 133(5):1064-73. PMID: 23400681
Neuroblastoma is the most common extracranial solid tumor of childhood, and accounts for ∼15% of all childhood cancer deaths. The histone demethylase, lysine-specific demethylase 1 (KDM1A, previously known as LSD1),...
23.
Sridhar S, Al-Moallem B, Kamal H, Terrile M, Stallings R
Mol Diagn Ther . 2013 Jan; 17(2):63-9. PMID: 23329364
Neuroblastoma is a genetically and clinically heterogeneous tumor of childhood, arising from precursor cells of the sympathetic nervous system. It is still a challenging cancer for pediatric oncology, as some...
24.
Domingo-Fernandez R, Watters K, Piskareva O, Stallings R, Bray I
Pediatr Surg Int . 2013 Jan; 29(2):101-19. PMID: 23274701
Neuroblastoma is a highly heterogeneous tumor accounting for 15 % of all pediatric cancer deaths. Clinical behavior ranges from the spontaneous regression of localized, asymptomatic tumors, as well as metastasized...
25.
Molenaar J, Domingo-Fernandez R, Ebus M, Lindner S, Koster J, Drabek K, et al.
Nat Genet . 2012 Oct; 44(11):1199-206. PMID: 23042116
LIN28B regulates developmental processes by modulating microRNAs (miRNAs) of the let-7 family. A role for LIN28B in cancer has been proposed but has not been established in vivo. Here, we...
26.
Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W, et al.
Genome Biol . 2012 Oct; 13(10):R95. PMID: 23034519
Background: Accurate outcome prediction in neuroblastoma, which is necessary to enable the optimal choice of risk-related therapy, remains a challenge. To improve neuroblastoma patient stratification, this study aimed to identify...
27.
McKiernan R, Jimenez-Mateos E, Sano T, Bray I, Stallings R, Simon R, et al.
Exp Neurol . 2012 Jul; 237(2):346-54. PMID: 22771761
Brief seizures (epileptic/seizure preconditioning) are capable of activating endogenous protective pathways in the brain which can temporarily generate a damage-refractory state against subsequent and otherwise harmful episodes of prolonged seizures...
28.
Jimenez-Mateos E, Engel T, Merino-Serrais P, McKiernan R, Tanaka K, Mouri G, et al.
Nat Med . 2012 Jun; 18(7):1087-94. PMID: 22683779
Temporal lobe epilepsy is a common, chronic neurological disorder characterized by recurrent spontaneous seizures. MicroRNAs (miRNAs) are small, noncoding RNAs that regulate post-transcriptional expression of protein-coding mRNAs, which may have...
29.
Tivnan A, Orr W, Gubala V, Nooney R, Williams D, McDonagh C, et al.
PLoS One . 2012 Jun; 7(5):e38129. PMID: 22662276
Background: Neuroblastoma is one of the most challenging malignancies of childhood, being associated with the highest death rate in paediatric oncology, underlining the need for novel therapeutic approaches. Typically, patients...
30.
McKiernan R, Jimenez-Mateos E, Bray I, Engel T, Brennan G, Sano T, et al.
PLoS One . 2012 May; 7(5):e35921. PMID: 22615744
Hippocampal sclerosis (HS) is a common pathological finding in patients with temporal lobe epilepsy (TLE) and is associated with altered expression of genes controlling neuronal excitability, glial function, neuroinflammation and...